Joliet, Illinois Clinical Trials

A listing of Joliet, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

fluorouracil
irinotecan
open biopsy
cancer
corticosteroids
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

carboplatin
carcinoma
paclitaxel
gemcitabine
platelet count
UC Comprehensive Cancer Center at Silver Cross
 (3.1 away) Contact site
  • 136 views
  • 01 Aug, 2021
  • +808 other locations
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune …

thyroid stimulating hormone
carboplatin
adenocarcinoma
brachytherapy
undifferentiated carcinoma
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 71 views
  • 01 Aug, 2021
  • +183 other locations
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the …

prednisone
vinblastine
doxorubicin
nivolumab
positron emission tomography/computed tomography
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 68 views
  • 01 Aug, 2021
  • +507 other locations
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer The PDIGREE Study

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body. The addition of cabozantinib to the …

ipilimumab
pd-l1
nivolumab
cancer
atezolizumab
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 157 views
  • 01 Aug, 2021
  • +677 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

androgens
antiandrogen therapy
external beam radiation therapy
cancer vaccine
tumor cells
Silver Cross Hospital
 (2.7 away) Contact site
  • 1420 views
  • 02 Aug, 2021
  • +78 other locations
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted …

UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +762 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

luteinizing hormone
vismodegib
dabrafenib
dolutegravir
metastatic cancer
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 6087 views
  • 01 Aug, 2021
  • +1020 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

octreotide
thyroidectomy
carcinoid
undifferentiated carcinoma
lepidic predominant adenocarcinoma
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 6047 views
  • 01 Aug, 2021
  • +814 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

non-melanoma skin cancer
beta human chorionic gonadotropin
carcinoma in situ
hemoglobin a1c
cancer
UC Comprehensive Cancer Center at Silver Cross
 (2.7 away) Contact site
  • 335 views
  • 28 Jul, 2021
  • +911 other locations